Comment on: A Soaring Price, a Silent Fight: Thioguanine Portends New Access Barriers to Life-Saving Treatments for Children With Cancer: The Ugly Duck or The Chicken with the Golden Eggs: The Crisis in Thioguanine Accessibility

Pediatr Blood Cancer. 2025 Feb;72(2):e31464. doi: 10.1002/pbc.31464. Epub 2024 Nov 30.

Ahmed B Bayoumy^{1

2}, Chris J J Mulder^{1

2}, Nanne K H De Boer^{1

2}, Luc J J Derijks^{3

4}, Jun J Yang^{5

6}, Kjeld Schmiegelow^{7

8}

¹ Department of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, The Netherlands.
² Amsterdam Gastroenterology Endocrinology Metabolism Research Institute, Amsterdam, The Netherlands.
³ Department of Clinical Pharmacy and Clinical Pharmacology, Máxima Medical Center, Veldhoven, The Netherlands.
⁴ Department of Clinical Pharmacy and Toxicology, Maastricht University Medical Center, Maastricht, The Netherlands.
⁵ Department of Pharmacy and Pharmaceutical Sciences, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
⁶ Department of Oncology, St. Jude Children's Research Hospital, Memphis, Tennessee, USA.
⁷ Department of Pediatrics and Adolescent Medicine, Rigshospitalet, Copenhagen, Denmark.
⁸ Department of Clinical Medicine, University of Copenhagen, Copenhagen, Denmark.

No abstract available

Publication types